Dark Daily Press Releases & News

Latest E-Briefings

Press Release: DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release: DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (June 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.